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Moraxella catarrhalis is an emerging human-restricted respiratory tract pathogen that is a common cause of
childhood otitis media and exacerbations of chronic obstructive pulmonary disease in adults. Here, we report
the first completely assembled and annotated genome sequence of an isolate of M. catarrhalis, strain RH4,
which originally was isolated from blood of an infected patient. The RH4 genome consists of 1,863,286
nucleotides that form 1,886 protein-encoding genes. Comparison of the RH4 genome to the ATCC 43617
contigs demonstrated that the gene content of both strains is highly conserved. In silico phylogenetic analyses
based on both 16S rRNA and multilocus sequence typing revealed that RH4 belongs to the seroresistant
lineage. We were able to identify almost the entire repertoire of known M. catarrhalis virulence factors and
mapped the members of the biosynthetic pathways for lipooligosaccharide, peptidoglycan, and type IV pili.
Reconstruction of the central metabolic pathways suggested that RH4 relies on fatty acid and acetate metab-
olism, as the genes encoding the enzymes required for the glyoxylate pathway, the tricarboxylic acid cycle, the
gluconeogenic pathway, the nonoxidative branch of the pentose phosphate pathway, the beta-oxidation pathway
of fatty acids, and acetate metabolism were present. Moreover, pathways important for survival under chal-
lenging in vivo conditions, such as the iron-acquisition pathways, nitrogen metabolism, and oxidative stress
responses, were identified. Finally, we showed by microarray expression profiling that 88% of the predicted
coding sequences are transcribed under in vitro conditions. Overall, these results provide a foundation for
future research into the mechanisms of M. catarrhalis pathogenesis and vaccine development.
Moraxella catarrhalis is an emerging human-restricted unen-
capsulated Gram-negative mucosal pathogen. Long considered
to be a commensal of the upper respiratory tract, this bacte-
rium has now firmly been established to be an etiological cause
of otitis media (OM) and exacerbations of chronic obstructive
pulmonary disease (COPD). It is the third most common cause
of childhood OM after Haemophilus influenzae and Streptococ-
cus pneumoniae (37, 64), and it is responsible for up to 20% of
the cases (64, 65). Further, M. catarrhalis is the second most
common cause of exacerbations of COPD after H. influenzae;
it is responsible for 10 to 15% of the exacerbations and annu-
ally causes 2 to 4 million episodes in the United States (47, 60).
Antibiotics are widely used for treatment of OM, but the high
prevalence of this disease and the increasing incidence of an-
tibiotic-resistant strains mean that multivalent vaccines, pref-
erably vaccines with protective antigens for all three causative
bacterial agents, must be developed (46).
M. catarrhalis is able to colonize the mucosal surfaces of the
middle ear in OM patients and the lower respiratory tract in
COPD patients (31, 60). Successful colonization of the human
host is a complex process which requires the expression of
adhesins and the activation of metabolic pathways to overcome
specific challenging environmental conditions, such as nutrient
limitation (15, 53). M. catarrhalis also possesses several mech-
anisms for evasion of the host immune system (15, 53), such as
the ability to withstand the action of the human complement
system. Importantly, most clinical isolates obtained from OM
or COPD patients are able to survive complement-mediated
killing by normal human serum (66).
Various molecular typing methods, such as 16S rRNA se-
quencing (8) and multilocus sequence typing (MLST) (71),
have shown that the species M. catarrhalis can be divided into
two distinct phylogenetic lineages, referred to as the serosen-
sitive and seroresistant lineages. The seroresistant, more viru-
lent lineage contains predominantly strains that are resistant to
complement-mediated killing and that are able to adhere to
epithelial cells (8, 71).
Even though our understanding of the molecular pathogen-
esis of M. catarrhalis has increased over the past few years, a
complete M. catarrhalis genome sequence would undoubtedly
be a valuable resource for improving our understanding of the
biology of this organism. At present, however, only a partial
genome of M. catarrhalis strain ATCC 43617 is available (59,
68). Here, we report the first completely assembled and anno-
tated genome sequence of M. catarrhalis strain RH4, which was
originally isolated from the blood of an infected patient (14),
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and we compared the gene content of this sequence to that of
the strain ATCC 43617 sequence. In silico phylogenetic typing
revealed that the RH4 strain belongs to the seroresistant lin-
eage. We were able to identify most of the known virulence
factors and reconstructed several important biochemical path-
ways, including central metabolic pathways and pathways for
nitrate metabolism, biosynthesis of lipooligosaccharides
(LOS), peptidoglycan, type IV pilus (TFP) biosynthesis, and
iron acquisition. In addition, several components that combat
oxidative stress were identified. Finally, we confirmed by tran-
scriptional profiling that most of the predicted coding se-
quences (CDSs) are expressed in vitro.
MATERIALS AND METHODS
Bacterial strain and growth conditions. M. catarrhalis strain RH4 was isolated
from the blood of an infected patient (14). RH4 was grown on Bacto brain heart
infusion (BHI) agar plates (Difco) in an atmosphere containing 5% CO2 at 37°C
or in broth at 37°C with agitation (200 rpm).
Sequencing of theM. catarrhalis RH4 genome. Whole-genome sequencing was
performed using a hybrid strategy consisting of Roche 454 and Illumina Solexa
sequencing by Agowa Genomics (Berlin, Germany). For Roche 454 sequencing,
genomic DNA was extracted using a Wizard genome purification kit (Promega),
after which a fragment library was prepared and sequenced using Roche stan-
dard procedures. This resulted in a total of 591,043 sequences with an average
read length of 224 bp covering approximately 134 Mb, which is more than 70-fold
coverage of the total genome. De novo assembly using the Roche 454 software
Newbler resulted in 44 contigs consisting of over 500 bp, which were aligned with
the 41 contigs of the ATCC 43617 strain (deposited in the NCBI database under
patent WO0078968; GenBank accession numbers AX067426 to AX067466) us-
ing the gap4 assembler program (Staden Package; Roger Staden, Cambridge,
United Kingdom). Gap closure by PCR and Sanger sequencing resulted in a
contiguous sequence consisting of 1,863,286 bp, which was verified using Solexa
sequencing as follows. Genomic DNA was isolated with a genomic DNA kit
(Qiagen), a fragment library (150 to 200 bp) was prepared using Illumina’s
standard genomic DNA library preparation procedure, and the library was se-
quenced with an Illumina Genome Analyzer II. The data were analyzed using the
standard Genome Analyzer pipeline, which yielded a total of 7,057,256 raw 36-bp
reads. The 454-assembled genome was corrected with Solexa short read se-
quence data using ROAST, a tool developed in house (S. A. F. T. van Hijum,
V. C. L. de Jager, B. Renckens, and R. J. Siezen, unpublished data). Briefly,
Solexa reads were aligned with the assembled genome sequence by using BLAT
(38). Alignment of reads with the reference sequence was allowed provided that
nucleotide substitutions (single nucleotide polymorphisms [SNPs]) or gaps (small
insertions or deletions [indels]) were at least 4 bp from the end of the read. Only
SNPs and indels were allowed, with a sequence depth of at least six reads
unanimously calling a genotype and with a maximum of one read indicating a
different genotype. Altogether, three SNPs, one insertion, and one deletion were
corrected in the reference genome sequence.
Annotation. Open reading frames (ORFs) and initial automated annotation
were obtained using both Pedant-Pro and the Institute for Genomics Sciences
(IGS) annotation engine (http://ae.igs.umaryland.edu/cgi/ae_pipeline_outline
.cgi), and the minimal ORF length was 90 nucleotides (nt). The IGS-derived
annotation was subjected to manual curation using the Pedant-Pro data, the
DBGET database (http://www.genome.jp/dbget/), and data described previously.
The putative origin of replication was identified using Ori-Finder (27), and bp 1
was assigned to the extreme of the CG disparity curve. Functional classification
of the predicted ORFs was based on the IGS functional classification, which was
manually improved with data from Clusters of Orthologous Groups (COGs) of
proteins and Nonsupervised Orthologous Groups (NOGs), both obtained by
searches using Signature (18).
A comparative genomic analysis of the RH4 and ATCC 43617 strains was
performed by alignment of the RH4 coding sequences (CDSs) with the ATCC
43617 contigs using BLAT (38). CDSs potentially unique to ATCC 43617 were
identified by alignment of the ATCC 43617 contigs with the RH4 sequence.
Pathway analysis was performed using the KEGG Pathway database (36) with
KEGG orthology (KO) identifiers and was complemented by pathway recon-
structions based on previously described data. KO identifiers were assigned with
the web-based KEGG automatic annotation server (KAAS) (http://www.genome
.jp/kegg/kaas/) using the bidirectional best-hit methods for a set of prokaryotic
reference genomes (organism codes prw, par, pcr, abm, aby, aci, ngo, nmc, hso,
nma, acb, apl, cvi, hin, hit, hip, and pmu), manually selected based on high
abundance in Pedant-Pro BlastP hits. The list acquired was complemented with
KO identifiers assigned by searching against the prokaryotic reference set. Fi-
nally, the RH4 genome was analyzed for the presence of clustered regularly
interspaced short palindromic repeat (CRISPR) regions using CRISPRFinder
(29).
The subcellular localization of the RH4 proteins was predicted by using an
extended version of the LocateP software (75) and was validated with a highly
curated list of Escherichia coli proteins. Protein localization prediction was tai-
lored for the Gram-negative organism M. catarrhalis by replacement of specific
Gram-positive components with tools suitable for Gram-negative bacteria (M.
Zhou, K. Mezger, S. A. F. T. van Hijum, and R. J. Siezen, unpublished data),
such as BOMP (7), CELLO (73), LipoP (35), and SecretomeP (6).
A detailed annotation, including localization prediction and comparative
genomics data, is shown in File S1 in the supplemental material.
In silico phylogenetic typing. The 16S rRNA type was determined as described
by Bootsma et al. (8). Multilocus sequence typing (MLST) of sequence frag-
ments of eight housekeeping genes was performed as described by Wirth et al.
(71). Allelic sequences were analyzed (http://mlst.ucc.ie/mlst/dbs/Mcatarrhalis)
and compared to the reference database containing 282 M. catarrhalis strains.
The lipooligosaccharide (LOS) serotype was determined by using the method
described by Edwards et al. (19), and copB typing was performed as described by
Verhaegh et al. (66).
Microarray expression profiling. Bacteria were grown in BHI medium at 37°C
with agitation (200 rpm), harvested by centrifugation at lag phase (optical density
at 620 nm [OD620], 0.2 to 0.3), exponential phase (OD620, 1.2 to 1.4), and
stationary phase (OD620, 2.0 to 2.2), and treated with 2 volumes of RNAprotect
bacterial reagent (Qiagen). Total RNA was extracted using an RNeasy minikit
(Qiagen), after which contaminating genomic DNA was removed by treatment
with DNase (DNAfree; Ambion). Total RNA was labeled essentially as de-
scribed by Ouellet et al. (51). Briefly, 10 g of RNA was incubated for 3 h with
7 g of 5 Cy3-labeled random nonamers (TriLink Biotechnologies) and Super-
script III reverse transcriptase (800 U; Invitrogen) under appropriate reaction
conditions (1 first-strand buffer, 5 mM dithiothreitol [DTT], 0.33 mM de-
oxynucleoside triphosphates [dNTPs], 21 mM actinomycin D [Sigma Aldrich], 40
U RNaseOut). After first-strand synthesis, RNA was degraded by incubation
with sodium hydroxide, which was followed by neutralization of the reaction
mixture with hydrochloric acid. Labeled cDNA was purified and concentrated
with CyScribe columns (GE Healthcare Life Sciences), followed by Micron-30
columns (Millipore). Two micrograms of labeled cDNA was applied in duplicate
to 4x72K custom-designed NimbleGen arrays. Overnight hybridization at 42°C
and subsequent washing of arrays were performed according to the manufactur-
er’s instructions. The Nimblegen array contained 1 to 118 probes per predicted
CDS with an average coverage of 15 probes per CDS, probes for both strands in
the CRISPR1 and CRISPR2 regions (no specific probes could be designed for
the putative CRISPR3 region), and 1,103 negative-control probes with a length
distribution and GC content similar to those of the experimental probes. Array
images were acquired with a NimbleGen MS200 scanner, and images were
processed with NimbleScan software using the RMA algorithm. Normalized and
background-corrected probe signal intensities obtained in this way were used to
calculate the median level of expression of the CDSs. An expression threshold
was defined by the median of the log2 signal intensity of the random control
probes plus four times the standard deviation. The levels of expression for CDSs
were classified as follows: low (log2 signal intensity, 10), moderate (log2 signal
intensity, 10 to 12.5), high (log2 signal intensity, 12.5), or none (4/6 replicates
[biological triplicate and technical duplicate] less than the threshold value).
Expression data for the RH4 predicted CDSs are shown in File S1 in the
supplemental material.
Nucleotide sequence and microarray data accession numbers. The genomic
sequence of M. catarrhalis RH4 has been deposited in the GenBank database
under accession number CP002005. Microarray data have been deposited in the
NCBI Gene Expression Omnibus (GEO) database (www.ncbi.nlm.nih.gov/geo/)
under GEO Series accession number GSE21632.
RESULTS AND DISCUSSION
General genome features and comparative genomics. The
RH4 genome (Fig. 1) consists of 1,863,286 nucleotides (nt),
and the overall GC content is 41.7%. Both the length and the
GC content are comparable to those of the unassembled,
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partial ATCC 43617 genome (1.9 Mb), which is represented
by 41 contigs (59, 68). The RH4 genome is predicted to include
1,964 genes, 1,886 of which are protein-encoding genes (Table
1), similar to the 1,761 to 1,849 ORFs predicted for ATCC
43617 (59, 68). Of the 1,886 protein-encoding genes predicted
for RH4, 63.6% could be assigned to a functional category
based on similarity of their products to proteins in public
databases, while the functions of 172 predicted proteins are
unknown. The products of the remaining 515 ORFs are clas-
TABLE 2. Functional classes of the predicted RH4 proteins
Functional class No. ofproteins
% of
total
Amino acid biosynthesis 77 4.0
Purines, pyrimidines, nucleosides, and nucleotides 36 1.9
Fatty acid and phospholipid metabolism 40 2.1
Biosynthesis of cofactors, prosthetic groups, and
carriers
90 4.7
Central intermediary metabolism 33 1.7
Energy metabolism 140 7.4
Transport and binding proteins 148 7.8
DNA metabolism 78 4.1
Transcription 35 1.8
Protein synthesis 141 7.4
Protein fate 89 4.7
Regulatory functions 31 1.6
Signal transduction 11 0.6
Cell envelope 168 8.8
Cellular processes 61 3.2
Mobile and extrachromosomal element functions 21 1.1
Unknown function 172 9.0
Hypothetical proteins 515 27.1
Disrupted reading frame 16 0.8
FIG. 1. Diagram of the M. catarrhalis RH4 genome. Gene coordinates are indicated. From the inside to the outside, the circles show the GC
skew, the GC content, the genes on the forward strand, and the genes on the reverse strand. The colors in the two outermost rings indicate the
functional classes of the genes and correspond to the colors in Table S1 in the supplemental material. The diagram was generated using CGview
(28).
TABLE 1. General genome features of RH4
Feature Value
Genome size (nt)......................................................................1,863,286
GC content (%) .................................................................... 41.7
No. of genes .............................................................................. 1,964
No. of protein-encoding ORFs............................................... 1,886
Avg ORF size (bp)................................................................... 850
Coding density (%) .................................................................. 86.1
No. of rRNA genes.................................................................. 12
No. of tRNA genes .................................................................. 50
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sified as either conserved hypothetical proteins (102 ORFs) or
hypothetical proteins (413 ORFs) (Table 2). The majority
(62%) of the best BlastP hit proteins were found to be
proteins of Psychrobacter species (data not shown).
Comparative genome analysis of the RH4 genome and the
ATCC 43617 contigs revealed that for 416 RH4 coding se-
quences (CDSs) there was an exact match in the ATCC 43617
genome (Table 3). When a maximum of 20% mismatches was
allowed, 1,252 full-length RH4 CDSs were identified in the
ATCC 46317 contigs. A total of 1,793 (95%) of the predicted
CDSs were found to be conserved in RH4 and ATCC 43617,
and a minimum of 80% of the CDSs were covered. As ex-
pected, RH4 genes encoding highly variable virulence factors,
such as members of the ubiquitous surface protein A (uspA)
family (10), showed lower levels of homology with ATCC
43617 sequences. Further, 68 CDSs were found to be unique to
RH4, 41 of which are annotated as genes encoding (conserved)
hypothetical proteins. Conversely, using the preliminary anno-
tation of the partial ATCC 43617 genome (68), 14 CDSs were
found to be unique to ATCC 43617, 12 of which encode hy-
pothetical proteins.
The RH4 genome contains genes encoding 50 tRNAs for all
20 amino acids. There are four identical rRNA operons (16S,
23S, and 5S rRNA genes) in which the 16S and 23S rRNA
genes are interspersed with genes encoding tRNAs for isoleu-
cine and alanine (Table 1). Genes encoding the RNA poly-
merase core subunits (, 	, 	, and 
), the 70 sigma factor,
and the alternative 32 sigma factor were identified, as were
genes encoding the transcription elongation factor GreA and
the transcription termination-antitermination factors NusA,
NusB, Rho, and NusG. Interestingly, the RH4 genome is pre-
dicted to encode only 32 transcription factors and 4 two-com-
ponent regulatory systems and to contain 2 orphan two-com-
ponent system genes. This raises the possibility that M.
catarrhalis has other, alternative mechanisms for adapting its
gene expression to changing environmental conditions, such as
phase-variable expression or noncoding RNA-based regula-
tion. Phase-variable expression has been described previously
for two M. catarrhalis virulence factors, ubiquitous surface pro-
tein A1 (UspA1) (40) and M. catarrhalis immunoglobulin D
binding protein (MID) (45), but a preliminary search for ad-
ditional homopolymeric tracts known to be involved in phase
variation did not result in discovery of novel candidates in the
RH4 genome. Clearly, further studies to elucidate the main
mechanism of transcriptional regulation in M. catarrhalis are
required.
In silico phylogenetic analysis classified RH4 as a 16S rRNA
type 1 strain (see Fig. S1A in the supplemental material); such
strains are predominantly members of the seroresistant lineage
(8). MLST analysis assigned RH4 to sequence type 128 (see
Fig. S1B in the supplemental material), like M. catarrhalis GRJ
11, which was isolated from a diseased individual in Salamanca
(Spain) and also belongs to the seroresistant lineage (71). In
line with this, experimental evidence also demonstrated that
RH4 has a seroresistant phenotype (data not shown).
Expression profiling. Microarray expression profiling for
three phases of in vitro growth in BHI medium (lag, exponen-
tial, and stationary) showed that 88.1% of the predicted CDSs
were expressed during at least one growth phase and that
84.6% of the predicted CDSs were expressed in all three
growth phases. Of the predicted CDSs for which no transcripts
were detected, 81% were annotated as (conserved) hypo-
thetical. Further, we observed expression for 30 of the 41
(conserved) hypothetical CDSs that were not present in the
ATCC 43617 strain. Expression of specific genes is discussed in
detail below.
Virulence factors. Various proteins have been described as
proteins that play pivotal roles in M. catarrhalis pathogenesis
(for recent reviews, see references 15 and 53), and all but one
of these proteins were found to be encoded by genes in the
RH4 genome (Table 4). The ubiquitous surface proteins
(UspAs) are among the major virulence factors; UspA1 mediates
binding to epithelial cells and extracellular matrix (ECM) com-
ponents, and the mutually exclusive UspA2 and UspA2H pro-
teins have a role predominantly in immune evasion (3, 39).
Determination of the modular structure of the predicted
UspA1 and UspA2H proteins (the strain did not possess a
uspA2 gene) revealed the presence of the VEEG-NINNY-
VEEG amino acid sequence motif involved in binding to
Chang conjunctival cells or fibronectin (10) in UspA1, whereas
this motif was not present in UspA2H (Fig. 2). RH4 contains
several other adhesins, namely, M. catarrhalis immunoglobulin
D (IgD) binding protein (MID) (also referred to as hemagglu-
tinin [Hag]) (22), the M. catarrhalis adherence protein (McaP)
(63), and outer membrane protein (OMP) CD (33). Resistance
to the action of the human complement system is an important
aspect of M. catarrhalis virulence. Previous studies have shown
that, in addition to the UspA proteins mentioned above, the M.
catarrhalis proteins CopB (32), OMP CD (33), and OMP E
(48) play a role in serum resistance, and the corresponding
genes are all present in RH4. All of the virulence factors
described above were found to be expressed at intermediate or
high levels during all three phases of in vitro growth examined.
Interestingly, the only known virulence locus not present in
RH4 is the mha locus encoding filamentous hemagglutinin-like
proteins involved in adhesion (4, 54). We did identify three
ORFs (MCR_0770, MCR_0777, and MCR_0778) with a small
region of homology (37 to 71 amino acids) to mhaB1, but
transcriptional profiling indicated that there was either no ex-
pression (MCR_0778) or low levels of expression (MCR_0770
and MCR_0777) of these loci.
Biosynthesis of cell wall structures. A prominent surface
component of M. catarrhalis that is generally considered to be
an important virulence factor is lipooligosaccharide (LOS).
Genes encoding LOS glycosyl transferases (Lgt), which are
enzymes that catalyze the formation of core or branched oli-
gosaccharide chains (43), as well as genes required for biogen-
TABLE 3. Comparison of M. catarrhalis RH4
and ATCC 43617 genomes
% RH4 CDSs in
alignment
% of mismatches
allowed in alignment
No. of
CDSs
% of
total
100 0 416 22.1
100 20 1,252 66.4
80 20 125 6.6
60–80 20 10 0.5
40–60 20 7 0.4
0–40 20 8 0.4
No match 68 3.6
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esis of the deoxy-D-manno-2-octulosonic acid (KDO)-lipid A
moiety (for a review, see reference 55), were all identified in
the RH4 genome (see Table S2 in the supplemental material)
Expression was detected for all components of the pathways
involved except lgt5, whose product catalyzes addition of the
terminal -(134)-linked terminal galactose of the core oligo-
saccharide chain (70) (see Table S2 in the supplemental ma-
terial). Analysis of the RH4 lgt locus (lgt5, lgt1, lgt2b/c, and lgt3)
revealed that RH4 is a LOS type B strain (see Fig. S1C in the
supplemental material) (19); LOS type B strains are exclusively
16S rRNA type 1 isolates (66).
The peptidoglycan layer is the main target for 	-lactam
antibiotics that can be degraded by the BRO 	-lactamases
produced by M. catarrhalis (RH4 expresses the bro-2 gene
[Table 4]) (9). The complete set of genes required for biosyn-
thesis of peptidoglycan (61) was identified in RH4 and was
found to be expressed in all growth phases (see Table S3 in the
supplemental material).
Type IV pili (TFP) have a wide variety of functions, includ-
ing adhesion to epithelial cells, biofilm formation, and motility
(44). Biogenesis of TFP is a complex process requiring a large
set of proteins (52), and the genes encoding these proteins are
present in the RH4 genome (see Table S4 in the supplemental
material). Overall, low levels of expression were detected for
most genes encoding components of the TFP pathway, except
for pilA, which encodes the major pilin subunit, which on
average was found to be highly expressed (see Table S4 in the
supplemental material).
Protein secretion. Gram-negative bacteria transport pro-
teins from the cytosol across the inner membrane (IM) to the
periplasm via one of two protein secretion systems, either the
Sec system or the Tat system (16, 41). RH4 was found to
contain complete Sec machinery, as well as the main compo-
nents of the Tat system (see Table S5 in the supplemental
material). After deposition in the periplasmic space, proteins
TABLE 4. Major virulence factors of M. catarrhalis RH4a
RH4 locus Gene Common name and general function of protein Characteristics
Level of expression in growth
phases in BHI mediumb
Lag Exponential Stationary
MCR_1198 uspA1 Ubiquitous surface protein A1; functions in
adhesion to epithelial cells and ECM
components, inhibition of NF-B
proinflammatory response via CEACAM
binding, serum resistance, binding of
complement regulatory proteins, and
biofilm formation
9 poly(G) repeats upstream of the ORF,
reported to correlate with a low level
of expressionc
  
MCR_0329 uspA2H Ubiquitous surface protein A2H; functions
in adhesion to epithelial cells, serum
resistance, and biofilm formation
  
MCR_0617 mid/hag Immunoglobulin D binding
protein/hemagglutinin; functions in
adhesion to epithelial cells and IgD
binding
3 triplets of G residues at 5 end within
the ORF, reported to correlate with a
high level of expressiond
  
MCR_0419 mcaP M. catarrhalis adherence protein; functions
in adhesion to epithelial cells
  
MCR_1698 ompCD Outer membrane protein CD; functions in
adhesion to epithelial cells and middle
ear mucin
RFLP pattern 1 (200- and 100-nt
BseJI restriction fragments), which is
almost exclusively found in 16S type 1
isolatese
  
MCR_0492 copB Outer membrane protein CopB; involved
in serum resistance and important for in
vivo survival
RFLP type II (332- and 187-nt NsaI
restriction fragments), which is found
almost exclusively in 16S rRNA type I
isolatese
  
MCR_0858 ompE Outer membrane protein E; involved in
serum resistance
Putative homolog of long-chain fatty
acid transporter FadL
  
MCR_1591 bro-2 Beta-lactamase family protein BRO-2   
a Abbreviations: ECM, extracellular matrix; ORF, open reading frame; RFLP, restriction fragment length polymorphism; nt, nucleotides.
b , moderate; , high. See text.
c See reference 40.
d See reference 45.
e See reference 66.
FIG. 2. Modular arrangement and functional domains of UspA1
(A) and UspA2H (B) of RH4. Both proteins are drawn to scale. The
various sequence cassettes and the known functional domains are
indicated. The VEEG repeats of UspA2H are indicated by asterisks
because they only partially match the repeat motif. Abbreviations:
CTER1, C-terminal region 1; CTER2, C-terminal region 2.
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reach their final destination by other means. For instance,
outer membrane lipoproteins are inserted into the outer mem-
brane by the components of the Lol system (49) (see Table S5
in the supplemental material). Furthermore, several ORFs are
predicted to encode components of resistance-nodulation-di-
vision (RND) efflux systems, such as components of the Acr
and Mtr systems (50); components of both of these systems
share homology with type I secretion system components (see
Table S5 in the supplemental material). Strikingly, no compo-
nents of the general secretory pathway, a type II secretion
system, were found, although all of the evolutionarily related
TFP assembly machinery (62) is present, as mentioned above.
Even though a homolog of the type III secretion effector
(HopJ) was identified (MCR_0582), other components of type
III secretion systems were not found, nor did we identify com-
ponents of type IV, V, and VI secretion systems. An overview
of protein secretion components and the expression levels de-
tected is shown in Table S5 in the supplemental material.
Protein localization prediction. A complete genome se-
quence provides an opportunity to discover novel vaccine tar-
gets, and surface-exposed and secreted proteins are of special
interest for vaccine development. Ruckdeschel et al. used a
genome mining approach on the partial genome sequence of
M. catarrhalis ATCC 43617, which led to discovery and animal
model testing of novel vaccine targets (58, 59). Extensive sub-
cellular localization prediction revealed that 134 (7.1%) of the
predicted RH4 proteins localize to the outer membrane or are
secreted into the extracellular environment. The surface-ex-
posed proteins include vaccine candidates, such as the lipid-
anchored outer membrane protein Msp22 (59) and OMP E
(48). In addition, we identified 35 (1.9%) proteins that are
predicted to localize to the cytoplasm but may be secreted via
nonclassical secretion pathways (i.e., not via the Sec or Tat
pathway), including, for example, the autotransporter McaP
(42). The subcellular compartment distribution of the pre-
dicted RH4 proteome is summarized in Table 5.
Central metabolic pathways. As a respiratory tract patho-
gen, M. catarrhalis is at least partially dependent on nutrients
available inside its human host to fill its needs for energy and
intermediates for biosynthesis of essential macromolecules. M.
catarrhalis is reported to be incapable of utilizing exogenous
carbohydrates and consequently does not produce acid from
carbohydrates (12). In line with this, no genes encoding car-
bohydrate transport or catabolism components were found in
the RH4 genome. Reconstruction of the central metabolism
(Fig. 3; see Table S6 in the supplemental material) showed that
while RH4 possesses an incomplete glycolytic pathway, all of
the enzymes of the gluconeogenic pathway are present, indi-
cating that carbohydrate intermediates can be synthesized.
Gluconeogenesis uses phosphoenolpyruvate (PEP) as a start-
ing substrate, which can be generated from tricarboxylic acid
(TCA) cycle intermediates. The TCA cycle is supplied with
acetyl coenzyme A (acetyl-CoA) via degradation of fatty acids
and acetate assimilation, and the genes required for these
processes were identified in RH4. The incomplete TCA cycle,
which lacks both subunits of succinyl-CoA synthetase, can be
bypassed by the glyoxylate pathway, which is complete in RH4.
The glyoxylate pathway has an anaplerotic function and sup-
plies the TCA cycle with oxaloacetate (acetyl-CoA acceptor
molecule). Furthermore, the enzymes required for oxidative
stages of the pentose phosphate pathway are not present, but
transaldolase and the enzymes of the nonoxidative branch are
present. As mentioned above, RH4 possesses all of the genes
required for beta-oxidation of long-chain fatty acids (see Table
S6 in the supplemental material) (23). Long-chain fatty acids
are transported across the cell membrane by the combined
action of the outer membrane protein FadL and the inner
membrane-associated FadD protein, an acyl-CoA synthase.
We predict that the highly conserved OMP E (48) is the FadL
homolog in RH4. Two adjacent ORFs (67% identical) appear
to encode homologs of FadD (aerobic) or its anaerobic coun-
terpart, FadK (13). Interestingly, we did not detect obvious
homologs of known fatty acid metabolism regulators, such as
FadR, although we did identify members of the family con-
taining such proteins, such as GntR and DeoR family regula-
tors (23). Unfortunately, no obvious function could be assigned
to these ORFs. Further, we identified two ORFs encoding
proteins with homology to the 3-oxoacid CoA transferase in-
volved in degradation of short-chain fatty acids (34). Finally,
we identified all of the genes encoding the enzymes required
for completion of fatty acid biosynthesis (23) (see Table S6 in
the supplemental material).
Expression profiling showed that all of the gluconeogenesis,
TCA cycle, fatty acid degradation, acetate assimilation, and
pentose phosphate pathway genes are expressed during in vitro
growth (see Table S6 in the supplemental material). However,
expression of malate synthase, the second enzyme of the
glyoxylate pathway, was not detectable in the lag and exponen-
tial phases of growth, and the levels during the stationary
growth phase were low. This suggests that glyoxylate is fur-
ther processed via other enzymes, e.g., glycerate dehydro-
genase (MCR_1529) and phosphoglycolate phosphatase
(MCR_0365), both of which were expressed at intermediate
levels in all growth phases.
Nitrogen metabolism. It has been suggested that in M. ca-
tarrhalis a truncated denitrification pathway (reduction of ni-
TABLE 5. Subcellular compartment distribution
of the predicted RH4 proteins
Subcellular localizationa No. ofproteins
% of
total
Cytoplasm, intracellular 1,284 68.1
Cytoplasm (possibly secreted via nonclassical
pathways), intracellular or secreted
35 1.9
Inner membrane, multitransmembrane 257 13.6
Inner membrane, multitransmembrane (lipid-
modified N terminus)
4 0.2
Inner membrane, C terminally anchored (with CS) 1 0.1
Inner membrane (periplasm), N terminally
anchored (no CS)
124 6.6
Inner membrane (periplasm), N terminally
anchored (with CS)
14 0.7
Inner membrane (periplasm), lipid anchored 12 0.6
Periplasm, secreted (with CS) 22 1.2
Outer membrane, lipid anchored 53 2.9
Outer membrane, 	-barrel protein (no CS) 19 1.0
Outer membrane, 	-barrel protein (with CS) 23 1.2
Outer membrane (no clear SP found but have 	-
barrel), intracellular or 	-barrel
20 1.1
Extracellular, secreted (with CS) 18 1.0
a Abbreviations: CS, cleavage site; SP, signal peptide.
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trite to nitrous oxide) described by Wang et al. provides an
alternative mechanism to generate energy under low-oxygen-
tension conditions and contributes to biofilm formation and in
vivo virulence. In diagnostic microbiological laboratories, re-
duction of nitrate is one of the differential tests used to confirm
the identity of M. catarrhalis (12). The genes encoding the
nitrate reductase complex (narGHJI), nitrite reductase (aniA),
nitric oxide reductase (norB), and the narX/narL two-compo-
nent system were identified in RH4 (see Table S7 in the sup-
plemental material). In addition, a putative regulator of fuma-
rate and nitrate reduction was identified; however, the true
function of this fumarate and nitrate regulator (FNR)/cyclic
AMP receptor protein (CRP) family member remains to be
elucidated (69). In addition to the nitrate ABC transport sys-
tem, encoded by nrtABCD, we identified two other candidates
that could play a role in nitrate and nitrite transport, namely,
NarK1 and a putative nitrate-nitrite transporter designated
NarK2 (see Table S7 in the supplemental material). The levels
of expression of the denitrification pathway components were
not uniform; e.g., the level of nitrate reductase expression
ranged from undetectable to low, whereas the level of nitrite
reductase expression was high during the lag and exponential
phases (see Table S7 in the supplemental material).
Iron acquisition. Iron is a key nutrient that is functionally
involved as a cofactor in various metabolic processes and is
essential for both M. catarrhalis and its human host (56). The
RH4 genome contains genes encoding components of many
iron acquisition and transport systems (see Table S8 in the
supplemental material), including all of the following M. ca-
tarrhalis proteins previously described as proteins involved in
this process: lactoferrin binding proteins A and B (17), trans-
ferrin binding proteins A and B (74), heme utilization protein
(25), M. catarrhalis hemoglobin utilization protein (26), CopB
(1), and the main regulator of iron-responsive genes, Fur (24).
In addition, iron may be acquired through degradation of
heme, which is catalyzed by a heme oxygenase. An iron trans-
FIG. 3. Predicted central metabolism of M. catarrhalis RH4. The glycolysis pathway is incomplete and lacks the key enzymes phosphofruc-
tokinase and pyruvate kinase. The enzymes of glycolysis are expected to be involved in the gluconeogenic pathway, all enzymes of which were found
to be present. Fatty acid degradation and acetate assimilation are probably very important, as they supply the tricarboxylic acid (TCA) cycle with
acetyl-CoA. The complete glyoxylate pathway is present and allows bypass of the TCA cycle, which lacks both subunits of succinyl-CoA synthetase.
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port system for transport of Fe3 from the periplasm to the
cytosol, encoded by the fbpABC gene cluster, was identified
based on homology to the corresponding locus in H. influenzae
(2). Further, the afeABCD gene cluster was identified in RH4;
this cluster has been proposed to be involved in the acquisition
of chelated iron, as described previously for Actinobacillus ac-
tinomycetemcomitans and Yersinia pestis, and is regulated by
Fur in these species (5, 57). Interestingly, the levels of expres-
sion of the iron binding components of the fbpABC and
afeABCD ABC transporter systems were higher than the levels of
expression of the other components of these systems. Two
putative NRAMP homologs, which are involved in transport of
Fe2 and Mn2, may compete with the host divalent ion trans-
porters of the NRAMP family (21). In addition, RH4 possesses
two putative bacterioferritins, which are intracellular iron stor-
age proteins important for preventing the presence of free iron
(11), both of which were found to be expressed at high levels
during all phases of growth. Overall, all of the iron acquisition
and transport systems of RH4 were found to be expressed in
vitro, but the importance of the individual pathways remains to
be investigated.
Oxidative stress. Inherent in aerobic metabolism is oxidative
stress caused by reactive oxygen species (ROS) (20). As men-
tioned above, acquisition of iron is essential for growth of M.
catarrhalis, but it can also be harmful for the bacterium, as iron
can react with hydrogen peroxide, resulting in the formation of
hydroxyl radicals via the Fenton reaction (20). The well-stud-
ied superoxide dismutase-catalase system is able to counteract
the effect of oxidative stress by catalyzing the conversion of
superoxide to water and oxygen. RH4 contains and expresses
the sodA and catalase genes, but it lacks the sodB gene (see
Table S9 in the supplemental material). Catalase production is
used during routine identification, but it has limited differential
value because not all strains produce catalase (12). Further,
RH4 was found to encode and express several putative bacte-
rial peroxiredoxins (Prx) that catalyze the reduction of perox-
ide, peroxynitrite, and diverse organic hydroperoxides
(ROOH) (72), as well as alkyl hydroperoxide reductase-thiore-
doxin family members (67). Despite the presence of a large
number of antioxidant genes in the RH4 genome, we could not
identify homologs of known oxidative stress regulators, such as
OxyR and SoxR (67).
CRISPR elements. Clustered regularly interspaced short
palindromic repeats (CRISPRs) are widespread in genomes of
prokaryotic organisms and are thought to be transcribed and
processed into small RNAs that confer resistance to phages
(30). CRISPR direct repeats are separated by nonrepetitive
spacer elements and are often located near gene clusters en-
coding CRISPR-associated (Cas) protein family members.
Two CRISPR regions, CRISPR regions I and II, and one
putative repeat region (CRISPR region III) were identified in
the RH4 genome. CRISPR region II, localized at nt 30997 to
28086, is in the vicinity of six genes encoding proteins with
significant homology to known Cas proteins, showing high lev-
els of similarity to the Yersinia pestis subtype (30). RH4
CRISPR regions I and II are characterized by an average
repeat length of 28.1 nt (Y. pestis, 28.0 nt) and a spacer length
of 32.0 nt (Y. pestis, 32.1 nt). Microarray analysis showed that
there was constitutive expression of both CRISPR region I and
CRISPR region II only from the minus strand (Fig. 4). In
addition, intermediate levels of expression of the six cas genes
were detected during all three growth phases (data not shown).
The exact role of the CRISPR system in M. catarrhalis remains
to be determined.
Conclusion. In this paper, we describe the completely as-
sembled and annotated genome of the clinically important
bacterial pathogen M. catarrhalis strain RH4. Comparative
genomics revealed high degrees of similarity and sequence
conservation for the RH4 and ATCC 43617 genomes. Like
RH4, the ATCC 43617 strain is classified as a 16S rRNA type
FIG. 4. Expression profiles of chromosomal CRISPR regions I (CRISPR1) and II (CRISPR2). The exponential-growth-phase log2 probe signal
intensities of both strands (open circles, reverse-strand probes; filled circles, forward-strand probes) demonstrate that there is reverse-strand
expression of both CRISPR1 and CRISPR2. The localization of CRISPR1 and CRISPR2 is indicated below the graph. Comparable results were
obtained during the lag and stationary growth phases (data not shown).
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1 strain (8), and MLST analysis showed that it also belongs to
the seroresistant lineage (71). The completely assembled and
annotated genome of a clinical isolate of M. catarrhalis de-
scribed here should facilitate identification of novel (surface-
exposed) vaccine targets, should provide the basis for omics-
based research, such as transcriptomics and proteomics
studies, and is indispensable for a complete understanding of
the biology of M. catarrhalis.
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